These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 36005828)

  • 41. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
    Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
    Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liquid Biopsy for Promising Non-invasive Diagnostic Biomarkers in Parasitic Infections.
    Ozturk EA; Caner A
    Acta Parasitol; 2022 Mar; 67(1):1-17. PubMed ID: 34176040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
    Lim M; Kim CJ; Sunkara V; Kim MH; Cho YK
    Micromachines (Basel); 2018 Feb; 9(3):. PubMed ID: 30424034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.
    Nonaka T; Wong DTW
    J Dent Res; 2018 Jun; 97(6):701-708. PubMed ID: 29513618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
    Bustamante P; Tsering T; Coblentz J; Mastromonaco C; Abdouh M; Fonseca C; Proença RP; Blanchard N; Dugé CL; Andujar RAS; Youhnovska E; Burnier MN; Callejo SA; Burnier JV
    J Exp Clin Cancer Res; 2021 Jun; 40(1):196. PubMed ID: 34134723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liquid Biopsy, ctDNA Diagnosis through NGS.
    Lin C; Liu X; Zheng B; Ke R; Tzeng CM
    Life (Basel); 2021 Aug; 11(9):. PubMed ID: 34575039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
    Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
    Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current and Developing Liquid Biopsy Techniques for Breast Cancer.
    Wu HJ; Chu PY
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer.
    Pourali G; Khalili-Tanha G; Nazari E; Maftooh M; Nassiri M; Hassanian SM; Mobarhan MG; Khazaei M; Ferns G; Avan A
    Curr Pharm Des; 2023; 29(10):748-765. PubMed ID: 36892023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
    Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M
    Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of liquid biopsy for surgical management of pancreatic cancer.
    Nagai M; Sho M; Akahori T; Nakagawa K; Nakamura K
    Ann Gastroenterol Surg; 2020 May; 4(3):216-223. PubMed ID: 32490335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers.
    Fernández-Lázaro D; García Hernández JL; García AC; Córdova Martínez A; Mielgo-Ayuso J; Cruz-Hernández JJ
    Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32294884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies.
    Tellez-Gabriel M; Knutsen E; Perander M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer.
    Yang F; Tang J; Zhao Z; Zhao C; Xiang Y
    Reprod Biol Endocrinol; 2021 Dec; 19(1):178. PubMed ID: 34861867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.